Текст книги "COVID-19/SARS-CoV-2"

553. L Ouyang, J Gong, M Yu. Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis. Int Immunopharmacol. 2021 Nov;100:108145. doi: 10.1016/j.intimp.2021.108145. Epub 2021 Sep 9.

554. R A Ghayda, K H Lee, Y J Han et al. The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis. J Med Virol. 2022 Jun;94 (6):2402—2413. doi: 10.1002/jmv.27610. Epub 2022 Feb 25.

555. A M Pezzullo, C Axfors, D G Contopoulos-Ioannidis et al. Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environ Res. 2023 Jan 1;216 (Pt 3):114655. doi: 10.1016/j. envres.2022.114655. Epub 2022 Oct 28.

556. D Plečko, N Bennett, J Mårtensson et al. Rapid Evaluation of Coronavirus Illness Severity (RECOILS) in intensive care: Development and validation of a prognostic tool for in-hospital mortality. Acta Anaesthesiol Scand. 2022 Jan;66 (1):65—75. doi: 10.1111/aas.13991. Epub 2021 Oct 15.

557. M S Alkodaymi, O A Omrani, N A Fawzy et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022 May;28 (5):657—666. doi: 10.1016/j.cmi.2022.01.014. Epub 2022 Feb 3.

558. J W Martha, R Pranata, A Wibowo et al. Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis. Int J Infect Dis. 2021 Apr;105:351—356. doi: 10.1016/j. ijid.2021.02.029. Epub 2021 Feb 11.

559. Y Zhao, L Yin, J Patel et al. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis. J Med Virol. 2021 Jul;93 (7):4358—4369. doi: 10.1002/jmv.26951. Epub 2021 Apr 1.

560. Global Burden of Disease Long COVID Collaborators; S W Hanson, C Abbafati, J G Aerts et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022 Oct 25;328 (16):1604—1615. doi: 10.1001/jama.2022.18931.

561. E R Smith, E Oakley, G Wable Grandner et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. 2023 Feb;228 (2):161—177. doi: 10.1016/j. ajog.2022.08.038. Epub 2022 Aug 24.

562. G Llauradó, B Vlacho, M Wargny et al. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19) Cardiovasc Diabetol. 2022 Oct 19;21 (1):216. doi: 10.1186/s12933-022-01657-8.

563. W Mude, V M Oguoma, T Nyanhanda et al. Racial disparities in COVID-19 pandemic cases, hospitalisations, and deaths: A systematic review and meta-analysis. J Glob Health. 2021 Jun 26;11:05015. doi: 10.7189/jogh.11.05015.

564. C M Chiesa-Estomba, J R Lechien, C Calvo-Henríquez et al. Systematic review of international guidelines for tracheostomy in COVID-19 patients. Oral Oncol. 2020 Sep;108:104844. doi: 10.1016/j. oraloncology.2020.104844. Epub 2020 Jun 5.

565. M Garg, X Li, P Moreno et al. Meta-analysis of COVID-19 single-cell studies confirms eight key immune responses. Sci Rep. 2021 Oct 21;11 (1):20833. doi: 10.1038/s41598-021-00121-z.

566. J S El-Sayed Moustafa, A U Jackson, S M Brotman et al. ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19. Int J Obes (Lond). 2022 Aug;46 (8):1478—1486. doi: 10.1038/s41366-022-01136-w. Epub 2022 May 20.

567. A A Koutalos, M P Ntalouka, F A Angelis et al. Venous thromboembolism and major adverse cardiovascular events in patients with hip fractures suffering from SARS-CoV-2 infection: a systematic review. Hip Int. 2022 Oct 25;11207000221132489. doi: 10.1177/11207000221132489. Online ahead of print.

568. T Klepinowski, M Klepinowska, L Sagan et al. Does SARS-CoV-2 Affect Human Semen? A Systematic Review and Meta-Analysis. Arch Sex Behav. 2023 Jan 5;1—9. doi: 10.1007/s10508-022-02520-3. Online ahead of print.

569. Y Okita, T Morita, A Kumanogoh. Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis. Inflamm Regen. 2022 Jun 1;42 (1):16. doi: 10.1186/s41232-022-00205-x.

570. X Yang, H Zhang, W Bao et al. Immunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis. Vaccines (Basel). 2022 Dec 2;10 (12):2070. doi: 10.3390/vaccines10122070.

571. E Schieffer, B Schieffer. The rationale for the treatment of long-Covid symptoms – A cardiologist’s view. Front Cardiovasc Med. 2022 Sep 15;9:992686. doi: 10.3389/fcvm.2022.992686. eCollection 2022.

572. R Joshi, R Singla, A Mishra et al. A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines. New Microbes New Infect. 2022 Jan;45:100949. doi: 10.1016/j. nmni.2022.100949. Epub 2022 Jan 7.

573. H R Mathew, M Y Choi, M D Parkins et al. Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic. BMC Pulm Med. 2021 May 20;21 (1):173. doi: 10.1186/s12890-021-01528-0.

574. F Mei, M Rota, M Bonifazi et al. Diagnostic Role of Bronchoalveolar Lavage in Patients with Suspected SARS-CoV-2 Pneumonia and Negative Upper Respiratory Tract Swab: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Aug 9;11 (16):4656. doi: 10.3390/jcm11164656.

575. S Alhumaid, A Al Mutair, J Alali et al. Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis. Diseases. 2022 Dec 1;10 (4):118. doi: 10.3390/diseases10040118.

576. Z Du, S Wang, Y Bai et al. Within-host dynamics of SARS-CoV-2 infection: A systematic review and meta-analysis. Transbound Emerg Dis. 2022 Jul 30;10.1111/tbed.14673. doi: 10.1111/tbed.14673. Online ahead of print.

577. V Lebar, A S Laganà, V Chiantera et al. The Effect of COVID-19 on the Menstrual Cycle: A Systematic Review. J Clin Med. 2022 Jun 30;11 (13):3800. doi: 10.3390/jcm11133800.

578. F Nappi, P Nappi, I Gambardella et al. Thromboembolic Disease and Cardiac Thrombotic Complication in COVID-19: A Systematic Review. Metabolites. 2022 Sep 22;12 (10):889. doi: 10.3390/metabo12100889.

579. H A Cheema, U Jafar, A A Elrashedy et al. Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis. J Infect. 2022 Dec;85 (6):702—769. doi: 10.1016/j. jinf.2022.10.012. Epub 2022 Oct 13.

580. J J Ferraro, A Reynolds, S Edoigiawerie et al. Associations between SARS-CoV-2 infections and thrombotic complications necessitating surgical intervention: A systematic review. World J Methodol. 2022 Nov 20;12 (6):476—487. doi: 10.5662/wjm. v12.i6.476.

581. X Chen, Z Chen, A S Azman et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysismedRxiv. 2020 Oct 29;2020.09.11.20192773. doi: 10.1101/2020.09.11.20192773. Preprint.

582. A Watanabe, R Kani, M Iwagami et al. Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis. JAMA Pediatr. 2023 Jan 23. doi: 10.1001/jamapediatrics.2022.6243. Online ahead of print.

583. S S Rao, K Parthasarathy, V Sounderrajan et al. Susceptibility of SARS Coronavirus-2 infection in domestic and wild animals: a systematic review. 3 Biotech. 2023 Jan;13 (1):5. doi: 10.1007/s13205-022-03416-8. Epub 2022 Dec 11.

584. M Riccò, A Zaniboni, E Satta et al. Potential Use of Exhaled Breath Condensate for Diagnosis of SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2022 Sep 17;12 (9):2245. doi: 10.3390/diagnostics12092245.

585. M Mbwogge. Mass Testing With Contact Tracing Compared to Test and Trace for the Effective Suppression of COVID-19 in the United Kingdom: Systematic Review. JMIRx Med. 2021 Apr 12;2 (2):e27254. doi: 10.2196/27254. eCollection 2021 Apr-Jun.

586. N Bobrovitz, H Ware, X Ma et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023 Jan 18;S1473—3099 (22) 00801—5. doi: 10.1016/S1473—3099 (22) 00801—5. Online ahead of print.

587. Barreto-Filho, J.A.; Seabra-Garcez, J.D.; Garcez, F.B.; et al. Nondyspnogenic acute hypoxemic respiratory failure in COVID-19 pneumonia. J. Appl. Physiol. 2021, 130, 892—897.

588. Nouri-Vaskeh, M.; Sharifi, A.; Khalili, N.; et al. Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism. Clin. Neurol. Neurosurg. 2020, 198, 106217.

589. Ur, A.; Verma, K. Happy Hypoxemia in COVID-19-A Neural Hypothesis. ACS Chem. Neurosci. 2020, 11, 1865—1867.

590. Gonzalez-Duarte, A.; Norcliffe-Kaufmann, L. Is «happy hypoxia’ in COVID-19 a disorder of autonomic interoception? A hypothesis. Clin. Auton. Res. 2020, 30, 331—333.

591. F Gentile, T Bocci, S Coppola et al. Putative Role of the Lung-Brain Axis in the Pathogenesis of COVID-19-Associated Respiratory Failure: A Systematic Review. Biomedicines. 2022 Mar 21;10 (3):729. doi: 10.3390/biomedicines10030729.

592. A Beigi-Khoozani, A Merajikhah, M Soleimani. Magnetic Resonance Imaging Findings of Olfactory Bulb in Anosmic Patients with COVID-19: A Systematic Review. Chin Med Sci J. 2022 Mar 7;37 (1):23—30. doi: 10.24920/003982. Online ahead of print.

593. M Matuszewski, L Szarpak, Z Rafique et al. Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Nov 7;11 (21):6600. doi: 10.3390/jcm11216600.

594. E Carrara, E Razzaboni, A M Azzini et al. Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis. Hematol Oncol. 2022 Oct 13;10.1002/hon.3084. doi: 10.1002/hon.3084. Online ahead of print.

595. S N Ehaideb, M L Abdullah, B Abuyassin et al. Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review. Crit Care. 2020 Oct 6;24 (1):594. doi: 10.1186/s13054-020-03304-8.

596. X Ou, J Jiang, B Lin et al. Antibody responses to COVID-19 vaccination in people with obesity: A systematic review and meta-analysis. Influenza Other Respir Viruses. 2023 Jan;17 (1):e13078. doi: 10.1111/irv.13078. Epub 2022 Dec 19.

597. S Alahyari, M Moradi, M Rajaeinejad et al. Post-COVID-19 hematologic complications: a systematic review. Expert Rev Hematol. 2022 Jun;15 (6):539—546. doi: 10.1080/17474086.2022.2080051. Epub 2022 May 26.

598. T Dzinamarira, S J Nkambule, M Hlongwa et al. Risk Factors for COVID-19 Infection Among Healthcare Workers. A First Report From a Living Systematic Review and meta-AnalysisSaf Health Work. 2022 Sep;13 (3):263—268. doi: 10.1016/j.shaw.2022.04.001. Epub 2022 Apr 12.

599. A Watanabe, J Yasuhara, M Iwagami et al. Peripartum Outcomes Associated With COVID-19 Vaccination During Pregnancy: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022 Oct 3;176 (11):1098—1106. doi: 10.1001/jamapediatrics.2022.3456. Online ahead of print.

600. L C Pezzaioli, E Gatta, F Bambini et al. Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature. Front Endocrinol (Lausanne). 2022 Nov 10;13:1027047. doi: 10.3389/fendo.2022.1027047. eCollection 2022.

601. C Patel, K Parmar, D Patel et al. Effect of corticosteroid therapy on mortality in COVID-19 patients-A systematic review and meta-analysis. Rev Med Virol. 2022 Sep;32 (5):e2386. doi: 10.1002/rmv.2386. Epub 2022 Aug 15.

602. S-H Lan, C-C Lai, S-P Chang et al. Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Expert Rev Clin Pharmacol. 2022 Jun;15 (6):759—766. doi: 10.1080/17512433.2022.2078701. Epub 2022 May 30.

603. I Sitaras, H Jacobsen, M M Higdon et al. Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant. NPJ Vaccines. 2022 Nov 15;7 (1):147. doi: 10.1038/s41541-022-00565-y.

604. P T Meyer, S Hellwig, G Blazhenets, J A Hosp. Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review. J Nucl Med. 2022 Jul;63 (7):971—980. doi: 10.2967/jnumed.121.263085. Epub 2022 Feb 17.

605. M R Donovan, A Miglani, D Lal, M J Marino. Factors associated with invasive fungal sinusitis in patients with COVID-19: A systematic review and single-center case series. Laryngoscope Investig Otolaryngol. 2022 Jun 15;7 (4):913—919. doi: 10.1002/lio2.833. eCollection 2022 Aug.

606. I Ahmed, R Mustafaoglu, I Yeldan et al. Effect of Pulmonary Rehabilitation Approaches on Dyspnea, Exercise Capacity, Fatigue, Lung Functions, and Quality of Life in Patients With COVID-19: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2022 Oct;103 (10):2051—2062. doi: 10.1016/j. apmr.2022.06.007. Epub 2022 Jul 29.

607. N Kurra, P I Woodard, N Gandrakota et al. Opportunistic Infections in COVID-19: A Systematic Review and Meta-AnalysisCureus. 2022 Mar 31;14 (3):e23687. doi: 10.7759/cureus.23687. eCollection 2022 Mar.

608. W Hu, Y Zhu, Y Wu et al. Impact of COVID-19 pandemic on the pregnancy outcomes of women undergoing assisted reproductive techniques (ARTs): a systematic review and meta-analysis. J Zhejiang Univ Sci B. 2022 Aug 15;23 (8):655—665. doi: 10.1631/jzus. B2200154.

609. X Xu, Y Feng, Y Jia et al.Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis. Thromb Res. 2022 Oct;218:83—98. doi: 10.1016/j.thromres.2022.08.017. Epub 2022 Aug 18.

610. N Sittichai, N Parasin, S Saokaew et al. Effects of physical activity on the severity of illness and mortality in COVID-19 patients: A systematic review and meta-analysis. Front Physiol. 2022 Nov 8;13:1030568. doi: 10.3389/fphys.2022.1030568. eCollection 2022.

611. J Huang, Z Fang, Y Liu et al. Effect of female COVID-19 vaccination on assisted reproductive outcomes: a systematic review and meta-analysis. Fertil Steril. 2023 Jan 23;S0015—0282 (23) 00062—6. doi: 10.1016/j. fertnstert.2023.01.024. Online ahead of print.

612. K Zhan, L Weng, Li Qi et al. Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis. Ann Pharmacother. 2022 Oct 29;10600280221133577. doi: 10.1177/10600280221133577. Online ahead of print.

613. C Janssen, A Mosnier, G Gavazzi et al. Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies. Hum Vaccin Immunother. 2022 Nov 30;18 (6):2131166. doi: 10.1080/21645515.2022.2131166. Epub 2022 Oct 18.

614. R Kumavath, D Barh, B S Andrade et al. The Spike of SARS-CoV-2: Uniqueness and ApplicationsFront Immunol. 2021 Jul 8;12:663912. doi: 10.3389/fimmu.2021.663912. eCollection 2021.

615. Wahba L, Jain N, Fire AZ, Shoura MJ, Artiles KL, McCoy MJ, et al. Identification of a Pangolin Niche for a 2019-Ncov-Like Coronavirus Through an Extensive Meta-Metagenomic Search. mSphere (2020) 5 (3):e00160—20. doi: 10.1101/2020.02.08.939660.

616. Wong MC, Javornik Cregeen SJ, Ajami NJ, Petrosino JF. Evidence of Recombination in Coronaviruses Implicating Pangolin Origins of Ncov-2019. bioRxiv (2020). doi: 10.1101/2020.02.07.939207.

617. Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou J-J, et al. Isolation of SARS-CoV-2-Related Coronavirus From Malayan Pangolins. Nature (2020) 583 (7815):286—9. doi: 10.1038/s41586-020-2313-x.

618. Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol (2016) 3 (1):237—61. doi: 10.1146/annurev-virology-110615-042301

619. Ou X, Liu Y, Lei X, et al. Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and Its Immune Cross-Reactivity With SARS-CoV. Nat Commun (2020) 11 (1). doi: 10.1038/s41467-020-15562-9.

620. Jaimes JA, Millet JK, Stout AE, André NM, Whittaker GR. A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses. Viruses (2020) 12 (1). doi: 10.3390/v12010083.

621. Hoffmann M, Kleine-Weber H. Pöhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol Cell (2020) 78 (4):779—84.e5. doi: 10.1016/j.molcel.2020.04.022.

622. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The Proximal Origin of SARS-CoV-2. Nat Med (2020) 26 (4):450—2. doi: 10.1038/s41591-020-0820-9.

623. Ou J, Zhou Z, Dai R, Zhao S, Wu X, Zhang J, et al. Emergence of SARS-CoV-2 Spike RBD Mutants That Enhance Viral Infectivity Through Increased Human ACE2 Receptor Binding Affinity. bioRxiv (2020). doi: 10.1101/2020.03.15.991844.

624. Chen J, Wang R, Wang M, Wei G-W. Mutations Strengthened SARS-CoV-2 Infectivity. J Mol Biol (2020) 432 (19):5212—26. doi: 10.1016/j.jmb.2020.07.009.

625. Wang C, Wang S, Li D, Zhao X, Han S, Wang T, et al. Lectin-Like Intestinal Defensin Inhibits 2019-Ncov Spike Binding to ACE2. bioRxiv (2020). doi: 10.1101/2020.03.29.013490.

626. Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity. Science (2020) 370 (6518):856—60. doi: 10.1126/science. abd2985.

627. Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Karteris E, et al. Neuropilin1 as a New Potential SARSCoV2 Infection Mediator Implicated in the Neurologic Features and Central Nervous System Involvement of COVID19. Mol Med Rep (2020) 22 (5):4221—6. doi: 10.3892/mmr.2020.11510.

628. Kerslake R, Hall M, Randeva HS, Spandidos DA, Chatha K, Kyrou I, et al. Coexpression of Peripheral Olfactory Receptors With SARSCoV2 Infection Mediators: Potential Implications Beyond Loss of Smell as a COVID19 Symptom. Int J Mol Med (2020) 46 (3):949—56. doi: 10.3892/ijmm.2020.4646.

629. Zamorano Cuervo N, Grandvaux N. ACE2: Evidence of Role as Entry Receptor for SARS-CoV-2 and Implications in Comorbidities. Elife (2020) 9:e61390. doi: 10.7554/eLife.61390.

630. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, O’Meara MJ, et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. bioRxiv (2020). doi: 10.1101/2020.03.22.002386.

631. C P Viana Martins, C S F Xavier, L Cobrado. Disinfection methods against SARS-CoV-2: a systematic review. J Hosp Infect. 2022 Jan;119:84—117. doi: 10.1016/j. jhin.2021.07.014. Epub 2021 Oct 18.

632. S Kumar, P Sarma, Hp Kaur et al. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell. 2021 Jun;70:101497. doi: 10.1016/j. tice.2021.101497. Epub 2021 Jan 26.

633. C Fernández-de-Las-Peñas, M Navarro-Santana, G Plaza-Manzano et al. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2022 Jul 1;163 (7):1220—1231. doi: 10.1097/j.pain.0000000000002496. Epub 2021 Sep 23.

634. N Salari, A Vepa, A Daneshkhah et al. Efficacy of COVID-19 vaccines by race and ethnicity. Public Health. 2022 Jul;208:14—17. doi: 10.1016/j. puhe.2022.04.009. Epub 2022 May 5.

635. Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol, 2016; 3, 237—61. doi: 10.1146/annurev-virology-110615-042301.

636. Song ZQ, Xu YF, Bao LL, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 2019; 11, 59. doi: 10.3390/v11010059.

637. Tian SF, Hu WD, Niu L, et al. Pulmonary pathology of early-phase 2019 Novel Coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol, 2020; 15, 700—4. doi: 10.1016/j. jtho.2020.02.010.

638. Xu Z, Shi L, Wang YJ, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020; 8, 420—2. doi: 10.1016/S2213—2600 (20) 30076-X.

639. Xiao F, Tang MW, Zheng XB, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology, 2020; 158, 1831—3. doi: 10.1053/j.gastro.2020.02.055.

640. R Si Jing Tan, K T Ng, C Ee Xin et al. High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis. J Cardiothorac Vasc Anesth. 2022 Sep;36 (9):3576—3586. doi: 10.1053/j. jvca.2022.05.011. Epub 2022 May 13.

641. D Zaçe, E La Gatta, L Petrella et al. The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis. Vaccine. 2022 Oct 6;40 (42):6023—6034. doi: 10.1016/j.vaccine.2022.09.019. Epub 2022 Sep 12.

642. T Petrović, A Vijay, F Vučković et al. IgG N-glycome changes during the course of severe COVID-19: An observational study. EBioMedicine. 2022 Jul;81:104101. doi: 10.1016/j. ebiom.2022.104101. Epub 2022 Jun 27.

643. K M Goldstein, K Ghadimi, H Mystakelis et al. Risk of Transmitting Coronavirus Disease 2019 During Nebulizer Treatment: A Systematic Review. J Aerosol Med Pulm Drug Deliv. 2021 Jun;34 (3):155—170. doi: 10.1089/jamp.2020.1659. Epub 2021 Apr 21.

644. T Zhang, Q Mei, Z Zhang et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 2022 Nov 15;20 (1):444. doi: 10.1186/s12916-022-02656-y.

645. Y Li, J Tan, S Tan et al. Infection rate and factors affecting close contacts of COVID-19 cases: A systematic review. J Evid Based Med. 2022 Dec;15 (4):385—397. doi: 10.1111/jebm.12508. Epub 2022 Dec 13.

646. M E Flacco, C A Martellucci, V Baccolini et al. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis. Eur J Clin Invest. 2022 Oct;52 (10):e13845. doi: 10.1111/eci.13845. Epub 2022 Aug 8.

647. M Helfand, C Fiordalisi, J Wiedrick et al. Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection. Ann Intern Med. 2022 Apr;175 (4):547—555. doi: 10.7326/M21—4245. Epub 2022 Jan 25.

648. C S von Bartheld, M M Hagen, R Butowt. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia. ACS Chem Neurosci. 2021 Oct 6;12 (19):3535—3549. doi: 10.1021/acschemneuro.1c00542. Epub 2021 Sep 17.

649. F M Silva, J Lima, P P Teixeira et al. Risk of bias and certainty of evidence on the association between obesity and mortality in patients with SARS-COV-2: An umbrella review of meta-analyses. Clin Nutr ESPEN. 2023 Feb;53:13—25. doi: 10.1016/j.clnesp.2022.08.014. Epub 2022 Aug 17.

650. R Pellegrino, E Chiappini, A Licari et al. Prevalence and clinical presentation of long COVID in children: a systematic reviewEur J Pediatr. 2022 Dec;181 (12):3995—4009. doi: 10.1007/s00431-022-04600-x. Epub 2022 Sep 15.

651. J L Miller, M Tada, M Goto et al. Prediction models for severe manifestations and mortality due to COVID-19: A systematic review. Acad Emerg Med. 2022 Feb;29 (2):206—216. doi: 10.1111/acem.14447.

652. R Santa Cruz, C Irrazábal, L Gonzale et al. Analytic review and meta-analysis of awake prone positioning in patients with Covid-19. Med Intensiva (Engl Ed). 2022 Oct;46 (10):580—582. doi: 10.1016/j.medine.2021.11.021.

653. X Wang, S Stelzer-Braid, M Scotch et al. Detection of respiratory viruses directly from clinical samples using next-generation sequencing: A literature review of recent advances and potential for routine clinical use. Rev Med Virol. 2022 Sep;32 (5):e2375. doi: 10.1002/rmv.2375. Epub 2022 Jul 1.

654. Matta I, Laganà AS, Ghabi E, et al. COVID-19 transmission in surgical smoke during laparoscopy and open surgery: a systematic review. Minim Invasive Ther Allied Technol. 2022 Jun;31 (5):690—697. doi: 10.1080/13645706.2021.1982728. Epub 2021 Oct 6. PMID: 34612141.

655. Guihot A, Litvinova E, Autran B, Debré P, Vieillard V. Cell-Mediated Immune Responses to COVID-19 Infection. Front Immunol. 2020 Jul 3;11:1662. doi: 10.3389/fimmu.2020.01662. PMID: 32719687; PMCID: PMC7350607.

656. Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol. (2007) 81:9812—24. doi: 10.1128/JVI.01012—07.

657. Kopecky-Bromberg SA, Martínez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol. (2007) 81:548—57. doi: 10.1128/JVI.01782—06.

658. Paranjpe I, Russak A, De Freitas JK, Lala A, Miotto R, Vaid A, et al. Clinical characteristics of hospitalized Covid-19 patients in New York City. medRxiv. [Preprint]. (2020). doi: 10.1101/2020.04.19.20062117.

659. Stout-Delgado HW, Cho SJ, Chu SG, Mitzel DN, Villalba J, El-Chemaly S, et al. Age-dependent susceptibility to pulmonary fibrosis is associated with NLRP3 inflammasome activation. Am J Respir Cell Mol Biol. (2016) 55:252—63. doi: 10.1165/rcmb.2015—0222OC.

660. Jouan Y, Guillon A, Gonzalez L, Perez Y, Ehrmann S, Ferreira M, et al. Functional alteration of innate T cells in critically ill Covid-19 patients. medRxiv. [Preprint]. (2020). doi: 10.1101/2020.05.03.20089300.

661. Sapir T, Averch Z, Lerman B, et al. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19. Int J Mol Sci. 2022 Aug 3;23 (15):8606. doi: 10.3390/ijms23158606. PMID: 35955740; PMCID: PMC9369212.

662. Bortolotti, D.; Gentili, V.; Rizzo, S.; et al. TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms 2021, 9, 1820.

663. Asano, T.; Boisson, B.; Onodi, F.; et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci. Immunol. 2021, 6, eabl4348.

664. Alene, M.; Yismaw, L.; Assemie, M.A.; et al. Serial interval and incubation period of COVID-19: A systematic review and meta-analysis. BMC Infect. Dis. 2021, 21, 257.

665. Banerjee, A.K.; Blanco, M.R.; Bruce, E.A.; et al. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. Cell 2020, 183, 1325—1339.e1321.

666. Gordon, D.E.; Jang, G.M.; Bouhaddou, M.; et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020, 583, 459—468.

667. Xia, H.; Cao, Z.; Xie, X.; et al. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020, 33, 108234.

668. Kurahashi, Y.; Sutandhio, S.; Furukawa, K.; et al. Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections. Front. Immunol. 2022, 13, 773652.

669. Muecksch, F.; Weisblum, Y.; Barnes, C.O.; et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity 2021, 54, 1853—1868.e1857.

670. Moriyama, S.; Adachi, Y.; Sato, T.; et al. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants. Immunity 2021, 54, 1841—1852.e1844.

671. Bolouri, H.; Speake, C.; Skibinski, D.; et al. Benaroya Research Institute, C.-R.T. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. J. Clin. Investig. 2021, 131.

672. Astuti, I.; Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. 2020, 14, 407—412.

673. Lopez-Collazo, E.; Avendano-Ortiz, J.; Martin-Quiros, A.; Aguirre, L.A. Immune Response and COVID-19: A mirror image of Sepsis. Int. J. Biol. Sci. 2020, 16, 2479—2489.

674. Shen, X.R.; Geng, R.; Li, Q.; et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct. Target. Ther. 2022, 7, 83.

675. Zheng Q, Ma P, Feng Z. Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis. Neurol Sci. 2023 Jan;44 (1):13—17. doi: 10.1007/s10072-022-06453-6. Epub 2022 Oct 15. PMID: 36243893; PMCID: PMC9569170.

676. Afraie M, Mohammadzedeh P, Azami M, et al. The association of chronic liver disorders with exacerbation of symptoms and complications related to COVID-19: A systematic review and meta-analysis of cohort studies. Clin Respir J. 2022 Dec;16 (12):777—792. doi: 10.1111/crj.13552. Epub 2022 Oct 18. PMID: 36254683; PMCID: PMC9716710.

677. Andalib E, Faghani M, Zia Ziabari SM, et al. The Effectiveness of the Anteroom (Vestibule) Area on Hospital Infection Control and Health Staff Safety: A Systematic Review. Front Public Health. 2022 Apr 26;10:828845. doi: 10.3389/fpubh.2022.828845. PMID: 35558527; PMCID: PMC9086672.

678. Lin K, Huang H, Fang S, et al. Should patients with epilepsy be vaccinated against coronavirus disease 2019? A systematic review and meta-analysis. Epilepsy Behav. 2022 Sep;134:108822. doi: 10.1016/j. yebeh.2022.108822. Epub 2022 Jun 29. PMID: 35853315; PMCID: PMC9239978.

679. R. Xu, M. Shi, J. Li, et al. Construction of SARS-CoV-2 virus-like particles by mammalian expression system. Front. Bioeng. Biotechnol., 8 (2020), p. 862.

680. Lu W, Zhao Z, Huang YW, Wang B. Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic. Int J Biol Macromol. 2022 Mar 1;200:487—497. doi: 10.1016/j. ijbiomac.2022.01.108. Epub 2022 Jan 20. PMID: 35065135; PMCID: PMC8769907.

681. Fessler J, Jacobsen T, Lauritzen JB, Jørgensen HL. Mortality among hip fracture patients infected with COVID-19 perioperatively. Eur J Trauma Emerg Surg. 2021 Jun;47 (3):659—664. doi: 10.1007/s00068-021-01634-y. Epub 2021 Mar 11. PMID: 33704515; PMCID: PMC7947941.

682. Li X, Burn E, Duarte-Salles T, et al. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ. 2022 Oct 26;379:e071594. doi: 10.1136/bmj-2022-071594. PMID: 36288813; PMCID: PMC9597610.